Skip to main content

Advertisement

Log in

Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

The aim of this work is to study the different factors that affect the outcome of living donor liver transplantation for patients with hepatocellular carcinoma (HCC). Between April 2003 to November 2014, 62 patients with liver cirrhosis and HCC underwent living donor liver transplantation (LDLT) in the National Liver Institute, Menoufia University, Egypt. The preoperative, operative, and postoperative data were analyzed. After studying the pathology of explanted liver; 44 (71 %) patients were within the Milan criteria, and 18 (29 %) patients were beyond Milan; 13 (21.7 %) of patients beyond the Milan criteria were also beyond the University of California San Francisco criteria (UCSF) criteria. Preoperative ablative therapy for HCC was done in 22 patients (35.5 %), four patients had complete ablation with no residual tumor tissues. Microvascular invasion was present in ten patients (16 %) in histopathological study. Seven (11.3 %) patients had recurrent HCC post transplantation. The 1, 3, 5 years total survival was 88.7, 77.9, 67.2 %, respectively, while the tumor-free survival was 87.3, 82.5, 77.6 %, respectively. Expansion of selection criteria beyond Milan and UCSF had no increased risk effect on recurrence of HCC but had less survival rate than patients within the Milan criteria. Microvascular invasion was an independent risk factor for tumor recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Mejia A, Nazario H, Mantry P (2012) Liver transplantation for hepatocellular carcinoma. In: Abd Eldayem H, Allam N (eds) Liver transplantation—basic issues, vol 13, 1st edn. Intech, Croatia, pp 277–302

    Google Scholar 

  2. Abd Eldayem H (2014) Hepatocellular carcinoma. In: Abd Eldayem H (ed) Hepato-pancreato-biliary surgery, bottom lines, 1st edn. Publishing, Germany, 8: p 79–96

  3. Chan C (2013) Liver transplantation for hepatocellular carcinoma. Liver Cancer 2:338–344

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693–699

    Article  CAS  PubMed  Google Scholar 

  5. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394–1403

    Article  CAS  PubMed  Google Scholar 

  6. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM (2009) Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 49(3):832–838

    Article  PubMed  Google Scholar 

  7. Huo T, Hsu C, Huang Y, Su C, Lin H, Lee R et al (2010) Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy. BMC Gastroentrol 10:146

    Article  Google Scholar 

  8. Vibert E, Azoulay D, Hoti E, Lacopinelli S, Samuel D, Salloum C et al (2010) Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant 10:129–137

    Article  CAS  PubMed  Google Scholar 

  9. Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S et al (2007) The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 95:235–240

    Article  CAS  PubMed  Google Scholar 

  10. Baksh S, DeCaprio J, Burakoff S (2000) Calcineurin regulation of the mammalian G0/G1 checkpoint element, cyclin dependent kinase 4. Oncogene 19:2820–2827

    Article  CAS  PubMed  Google Scholar 

  11. Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Cavallari A et al (2005) Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Liver Transpl 11(5):497–503

    Article  PubMed  Google Scholar 

  12. Schwartz M, Roayaie S, Llovet J (2005) How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated? J Hepatol 43(4):584–589

    Article  PubMed  Google Scholar 

  13. Hollebecque A, Decaens T, Boleslawski E, Mathurin P, Duvoux C, Pruvot FR et al (2009) Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. Gastroenterol Clin Biol 33(5):361–369

    Article  CAS  PubMed  Google Scholar 

  14. Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boeker K et al (1999) Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 17(1):324–331

    Article  CAS  PubMed  Google Scholar 

  15. Sotiropoulos GC, Lang H, Nadalin S, Neuhäuser M, Molmenti EP, Baba HA et al (2007) Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors. J Am Coll Surg 205(5):661–675

    Article  PubMed  Google Scholar 

  16. Shimoda M, Ghobrial R, Carmody I, Anselmo D, Farmer D, Yersiz H et al (2004) Predictors of survival after liver transplantation for hepatocellular carcinoma associated with hepatitis C. Liver Transpl 10(12):1478–1486

    Article  PubMed  Google Scholar 

  17. Morris-Stiff G, Gomez D, de Liguori Carino N, Prasad KR (2009) Surgical management of hepatocellular carcinoma: is the jury still out? Surg Oncol 18(4):298–321

    Article  CAS  PubMed  Google Scholar 

  18. Kondili LA, Lala A, Gunson B, Hubscher S, Olliff S, Elias E et al (2007) Primary hepatocellular cancer in the explanted liver: outcome of transplantation and risk factors for HCC recurrence. Eur J Surg Oncol 33:868–873

    Article  CAS  PubMed  Google Scholar 

  19. Kornberg A, Küpper B, Tannapfel A, Katenkamp K, Thrum K, Habrecht O et al (2010) Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Eur J Surg Oncol 36:275–280

    Article  CAS  PubMed  Google Scholar 

  20. Li J, Yan L, Yang J, Chen Z, Li B, Zeng Y et al (2009) Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol 15(33):4170–4176

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hazem Mohamed Zakaria.

Ethics declarations

Financial Support

None.

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zakaria, H.M., Sallam, A.N., Ayoub, I.I. et al. Predictors of Outcome of Living Donor Liver Transplantation for Hepatocellular Carcinoma. Indian J Surg 79, 299–307 (2017). https://doi.org/10.1007/s12262-016-1474-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-016-1474-1

Keywords

Navigation